ClinicalTrials.gov
public full text
Public Domain
D3-GHR Polymorphism and Turner Syndrome
The protein polymorphism of the growth hormone receptor characterized by the genomic deletion of exon 3 has been linked to the magnitude of the first-year-growth response to growth hormone (GH) in girls with Turner syndrome. Objective: to study the long-term effect of GH therapy in Turner syndrome in correlation to this GHR polymorphism in a mainly retrospective design (chart-review).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Estrogen Treatment (Oral vs. Patches) in Turner Syndrome#844641
- THRB splice site variants lead to exon 4 skipping and TRβ1 gain-of-function syndrome#214809
- Loeys–Dietz syndrome with autoimmune polyendocrine syndrome type 4 and immune dysregulation associated with a heterozygous CD3G splice-site variant in a child: a case report#467475
- Data Sheet 1_Case Report: Anti-GQ1b antibody–positive overlap syndrome: a pediatric case involving the brainstem, spinal cord, and peripheral nerves.docx#430070
- The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: Findings from a pQCT case–control study#424474
Record · ID 866927
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive